Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/05/2009 | US20090275061 method to measure serum biomarkers for the diagnosis of liver fibrosis |
11/05/2009 | US20090275060 Determination of serum anti-mullerian hormone as a diagnostic test for spay in companion animals |
11/05/2009 | US20090275059 diagnosing the probability of the onset of a liver disease, prognosis of the liver disease by detecting or quantifying serum proteins; alcoholism |
11/05/2009 | US20090275058 Method for specific detection of salmonella spp. |
11/05/2009 | US20090275057 Diagnostic markers predictive of outcomes in colorectal cancer treatment and progression and methods of use thereof |
11/05/2009 | US20090275056 untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing the antigen; for cancers, autoimmune or inflammatory disorders |
11/05/2009 | US20090275055 Monoclonal Antibodies Specific to Denatured Human Class I Leucocyte Antigens |
11/05/2009 | US20090275054 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells |
11/05/2009 | US20090275053 Cell-based pcsk9 screening assay |
11/05/2009 | US20090275052 analysis apparatus copmrising a rotary motor, an optical energy conversion device, a signal molecular output device, a power resource system, a protective layer, a supporting material and a bilayer lipid membrane, used for detecting biological macromolecules and viruses |
11/05/2009 | US20090275051 Luminogenic and nonluminogenic multiplex assay |
11/05/2009 | US20090275050 14273 receptor, a novel G-protein coupled receptor |
11/05/2009 | US20090275049 EphA4 POLYPEPTIDE HAVING A NOVEL ACTIVITY AND USE THEREOF |
11/05/2009 | US20090275048 Anti-acharan sulfate antibody and its application |
11/05/2009 | US20090275047 Crystal structure of human soluble adenylate cyclase |
11/05/2009 | US20090275046 Complement factor H protein as a biomarker of Parkinson's disease |
11/05/2009 | US20090275044 Using E6 viral transcript expression as diagnostic indicator in detection and classification of cervical cancers |
11/05/2009 | US20090275041 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
11/05/2009 | US20090275036 Systems and methods for real time single molecule sequence determination |
11/05/2009 | US20090275033 Uses of BNIPXL-Beta in premature canities |
11/05/2009 | US20090275031 Biomolecular nano device |
11/05/2009 | US20090275021 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
11/05/2009 | US20090275020 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration |
11/05/2009 | US20090274804 Systems, methods and devices for use in assessing carcass grading |
11/05/2009 | US20090274802 Method for the Intelligent Continuous Filling of a Cooking Device and Cooking Device Therefor |
11/05/2009 | US20090274725 Materials and Methods for Detecting, Preventing, and Treating Retroviral Infection |
11/05/2009 | US20090274719 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
11/05/2009 | US20090274717 Genes and proteins, and their use |
11/05/2009 | US20090274711 LEVELS OF BLyS/APRIL HETEROTRIMERS IN SERUM AND USE IN DIAGNOSTIC METHODS |
11/05/2009 | US20090274705 Il-13 binding agents |
11/05/2009 | US20090274701 Chlamydia pneumoniae polynucleotides and uses thereof |
11/05/2009 | US20090274699 Ul16 binding protein 4 |
11/05/2009 | US20090274695 Inhibition of urokinase-type plasminogen activator (uPA) activity |
11/05/2009 | US20090274688 Antibodies to OPGL |
11/05/2009 | US20090274684 Methods for the Identification of Modulators of OSGPR114 or OSGPR78 Activity, and their use in the Treatment of Disease |
11/05/2009 | US20090274682 Demethylation and inactivation of protein phosphatase 2a |
11/05/2009 | US20090274680 Human Phospholipases |
11/05/2009 | US20090274666 B7-h1, a novel immunoregulatory molecule |
11/05/2009 | US20090274653 Interleukin-2 mutants with reduced toxicity |
11/05/2009 | US20090274649 Bispecific Antibody Point Mutations for Enhancing Rate of Clearance |
11/05/2009 | US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof |
11/05/2009 | US20090274624 Radiotracers for imaging p-glycoprotein function |
11/05/2009 | US20090274619 Tumor vasculature markers and methods of use therof |
11/05/2009 | US20090272655 Method for characterisation of the quality of sialoglycoproteins via an isoform number i |
11/05/2009 | US20090272204 Device and process for reducing an ethanol content of a liquid preparation |
11/05/2009 | US20090272180 Continuous testing device and continuous testing system |
11/05/2009 | US20090272174 Chemical vapor sensor system and method thereof |
11/05/2009 | DE102008021481A1 Gas content measuring device i.e. oil foaming measuring device, has sample container staying in effective connection with pressure increase producing device i.e. hydraulic device, in sealed sample container |
11/05/2009 | CA2725601A1 Supercharged proteins for cell penetration |
11/05/2009 | CA2723169A1 Substances and compositions for enhancing dna repair and methods of use |
11/05/2009 | CA2723162A1 Solid phase multi-analyte assay |
11/05/2009 | CA2723161A1 Non-proteolytic method for the determination of analytes in keratinized structures |
11/05/2009 | CA2722852A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
11/05/2009 | CA2722668A1 Methods for treating inflammation |
11/05/2009 | CA2722485A1 Use of sfrp-3 in the assessment of heart failure |
11/05/2009 | CA2722466A1 Dual variable domain immunoglobulins and uses thereof |
11/05/2009 | CA2722444A1 Acetaminophen assay |
11/05/2009 | CA2721998A1 Method of labeling sugar chain |
11/05/2009 | CA2721982A1 Assay for pathogenic conformers |
11/05/2009 | CA2720935A1 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules |
11/05/2009 | CA2720908A1 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
11/05/2009 | CA2720888A1 Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods |
11/05/2009 | CA2720854A1 Hemoglobin based bilirubin reference material |
11/05/2009 | CA2720651A1 Levels of blys/april heterotrimers in serum and use in diagnostic methods |
11/05/2009 | CA2720647A1 Levels of april in serum and use in diagnostic methods |
11/05/2009 | CA2688352A1 Hand-held trace vapor/particle detection system |
11/05/2009 | CA2630392A1 Bitumen froth treatment experimental system and method |
11/04/2009 | EP2113929A1 Method and device for determining the relative humidity of an insulating liquid filled electric apparatus |
11/04/2009 | EP2113774A2 PIGF and Flt-1 as prognostic parameters for cardiovascular illnesses |
11/04/2009 | EP2113773A2 Antibody complexes and methods for immunolabeling |
11/04/2009 | EP2113772A2 Induction of aging phenotypes |
11/04/2009 | EP2113771A2 Device, use of the device and method for producing a liquid flavour additive condensate |
11/04/2009 | EP2113770A1 Device and method to reduce the ethanol content of a liquid preparation |
11/04/2009 | EP2113764A2 Humidity control system for the sensing cell of an analyte permeation testing instrument |
11/04/2009 | EP2113562A1 Method of proteome analysis for phosphorylated protein |
11/04/2009 | EP2113257A1 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer |
11/04/2009 | EP2113083A1 Resealable container for storing moisture sensitive test elements |
11/04/2009 | EP2113082A1 Method and apparatus for obtaining heavy oil samples from a reservoir sample |
11/04/2009 | EP2113077A1 Method for assessing properties of fibre cement board |
11/04/2009 | EP2113075A1 Glazing inspection |
11/04/2009 | EP2113030A2 Genes involved in mitochondrial biogenesis |
11/04/2009 | EP2113009A1 Process for purification of water soluble polymers |
11/04/2009 | EP2112887A1 Method and apparatus for handling food pieces |
11/04/2009 | EP1996950B1 Infectivity assay |
11/04/2009 | EP1966610B1 Dual standard curve immunoassay |
11/04/2009 | EP1889064B1 Sensor system with actuated structure releasing a coloured indicator |
11/04/2009 | EP1883821B1 Automated glycofingerprinting strategy |
11/04/2009 | EP1769677B1 Method of identifying therapeutic compounds which can be used for the treatment and/or prevention of infections and diseases caused by human herpesviruses |
11/04/2009 | EP1735625B1 Screening for a modulator of atherogenic lipoprotein retention |
11/04/2009 | EP1700913B1 Fluorescent proteins |
11/04/2009 | EP1668373B1 Method for detecting procoagulant phospholipid |
11/04/2009 | EP1668114B1 Polypeptide display libraries and methods of making and using thereof |
11/04/2009 | EP1561105B1 Method for providing natural therapeutic agents with high therapeutic index |
11/04/2009 | EP1559721B1 Fprl1 ligands and use thereof |
11/04/2009 | EP1446387B1 Substituted aryl 1,4-pyrazine derivatives |
11/04/2009 | EP1250599B1 System for the internal qualitative and quantitative validation of marker indices |
11/04/2009 | EP1159421B1 Human suppressor of fused |
11/04/2009 | EP1125134B1 S100 proteins and autoantibodies as serum markers for cancer |
11/04/2009 | EP1032660B1 Method of identifying binding site domains that retain the capacity of binding to an epitop |
11/04/2009 | CN201340424Y Matching test-tube rack for fully-automatic enzyme immunoassay analyzer |